Trial intelligence / Profile preview

Midodrine and Tolvaptan in Cirrhosis with Refractory Ascites

NCT02173288Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Jul 2013
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of midodrine, tolvaptan in ascites, sponsored by Post Graduate Institute of Medical Education and Research. Started Jul 2013; status: completed.

02

Drugs

midodrinetolvaptan
03

Conditions

ascites

Beyond the preview

Go deeper on NCT02173288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02173288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call